DZRTR Dynamic Pharmaceutical Intellidex Total Return Index

This is the total return version of DZR. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The eight largest stocks by market capitalization collectively receive 40% of the total index weight (each of the eight largest stocks receives on average 5%). ii) The other twenty-two of the selected stocks collectively receive 60% of the total index weight (each of the twenty-two smaller stocks receives on average 2.73%).

As of 09/08/2017

Index Information
Provider:     ICE (NYSE)
Category1:  US Equity
Category2:  Single industry
Category3:  Biotechnology
Currency:    USD
Inception date:  02/28/2003
Backtesting data exists:   No
Weighting methodology:   Other
Methdology guide:  Read PDF
Number of holdings:  30
Total return version:  DZR

As explained in what is an index, there is no universal system of giving an index a symbol. You can search for indexes using our index symbol lookup.

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy